Kigali, Rwanda and Accra, Ghana -- Patrick Lukulay, PhD, Bio Usawa’s Chief Operating Officer, will represent Bio Usawa at the 2nd African Healthcare Manufacturing Trade Exhibition and Conference (AHMTEC) 7-9 October 2025 in Ghana. He will join two high-level conversations on how cross-sector collaboration, industrial strategy, and local innovation can accelerate Africa’s path toward sustainable healthcare manufacturing.

“At Bio Usawa, we believe that Africa’s health security begins with self-sufficiency in biotech manufacturing and equitable access to life-saving medicines — including life-saving biotherapies. AHMTEC embodies that shared mission.” said Dr. Lukulay.

If you’ll be at AHMTEC 2025, be sure to connect with Dr. Lukulay to explore collaboration opportunities — or book a meeting with him via [email protected]. 

About Bio Usawa Inc.

Bio Usawa is Rwanda's leading biotechnology company dedicated to democratizing access to life-saving biopharmaceuticals across Africa. Founded on the principle that geographic location should not determine healthcare outcomes, the company specializes in developing and manufacturing affordable, high-quality monoclonal antibodies targeting cancer, diabetes complications, infectious diseases, and autoimmune conditions. Bio Usawa's leadership team brings decades of experience from leading global biotech companies and international regulatory agencies.